US Patent 7473761 Somatostatin analogues
Patent 7473761 was granted and assigned to Novartis on January, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+240 characters)
Article
Patent abstract
The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07473761 Somatostatin analogues US Patent 7473761 Somatostatin analogues
Infobox
Patent Number
0747376100
Patent Number
747376100
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074737610
Date of Patent
January 6, 2009
0Patent Application Number
103432880
Date Filed
July 30, 2001
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074737610
Date of Patent
January 6, 2009
0Patent Application Number
103432880
Date Filed
July 30, 2001
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07473761 Somatostatin analogues
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07473761
Date of patent
January 6, 2009
Patent application number
10343288
Date Filed
July 30, 2001
Patent primary examiner
Find more entities like US Patent 7473761 Somatostatin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.